Skip to main content

Table 2 Adjusted odds ratios and 95% confidence intervals of the association of metabolic health and obesity with high-risk baPWV in 2017 (n = 2076)

From: Effect of metabolically healthy obesity on the development of arterial stiffness: a prospective cohort study

BMI and metabolic status No. with high baPWV (%) Unadjusted Model 1 Model 2 Model 3
MHNO 162 (13.6) 1.00 1.00 1.00 1.00
MUNO 63 (43.8) 4.92a (3.40–7.11) 4.87a (3.33–7.12) 4.05a (2.69–6.11) 5.05a(3.12–8.19)
MHO 102 (20.6) 1.64a (1.25–2.16) 1.44a (1.08–1.91) 1.19 (0.88–1.62) 0.99 (0.61–1.60)
MUO 126 (50.4) 6.43a (4.77–8.66) 5.76a (4.24–7.84) 4.49a (3.21–6.29) 4.56a (2.60–8.00)
  1. baPWV, brachial-ankle pulse wave velocity; BMI, body mass index; MHNO, metabolically healthy nonobesity, MUNO, metabolically unhealthy nonobesity; MHO, metabolically healthy obesity; MUO, metabolically unhealthy obesity
  2. MHNO was the reference group
  3. Model 1: adjusted for age and sex;
  4. Model 2: based on model 1 and history of hypertension, history of diabetes mellitus, history of hyperlipemia, smoke habits and alcohol consumption
  5. Model 3: based on model 2 and further adjusted for BMI, fasting plasma glucose, total cholesterol, triglycerides, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, urinary albumin-to-creatinine ratio and estimated glomerular filtration rate in 2017
  6. asignificant values